Summit Creek Advisors’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.5M | Sell |
105,679
-44,317
| -30% | -$4.22M | 2.37% | 13 |
|
|
2025
Q4 | $12.2M | Sell |
149,996
-5,907
| -4% | -$509K | 1.91% | 25 |
|
|
2025
Q3 | $13.6M | Sell |
155,903
-12,481
| -7% | -$1.11M | 1.99% | 27 |
|
|
2025
Q2 | $14M | Sell |
168,384
-7,308
| -4% | -$611K | 1.95% | 27 |
|
|
2025
Q1 | $14.7M | Sell |
175,692
-167
| -0.1% | -$15.5K | 2.15% | 23 |
|
|
2024
Q4 | $16.2M | Sell |
175,859
-26,907
| -13% | -$2.59M | 2.13% | 21 |
|
|
2024
Q3 | $18.8M | Sell |
202,766
-12,230
| -6% | -$1.06M | 2.56% | 12 |
|
|
2024
Q2 | $17.7M | Sell |
214,996
-14,940
| -6% | -$1.1M | 2.42% | 13 |
|
|
2024
Q1 | $15.3M | Buy |
229,936
+1,435
| +0.6% | +$88.5K | 1.92% | 25 |
|
|
2023
Q4 | $13M | Buy |
228,501
+62,737
| +38% | +$3.29M | 1.74% | 32 |
|
|
2023
Q3 | $9.03M | Buy |
165,764
+24,562
| +17% | +$1.46M | 1.23% | 39 |
|
|
2023
Q2 | $9.5M | Sell |
141,202
-96,838
| -41% | -$5.91M | 1.19% | 39 |
|
|
2023
Q1 | $12.3M | Buy |
238,040
+1,737
| +0.7% | +$84.3K | 1.59% | 29 |
|
|
2022
Q4 | $10.9M | Buy |
236,303
+186
| +0.1% | +$8.71K | 1.48% | 33 |
|
|
2022
Q3 | $12M | Sell |
236,117
-127,622
| -35% | -$6.38M | 1.65% | 31 |
|
|
2022
Q2 | $16.6M | Buy |
363,739
+148
| +0% | +$6.62K | 2.11% | 22 |
|
|
2022
Q1 | $16.9M | Buy |
363,591
+2,232
| +0.6% | +$99.9K | 1.91% | 25 |
|
|
2021
Q4 | $18.2M | Buy |
361,359
+62,754
| +21% | +$3.24M | 1.82% | 28 |
|
|
2021
Q3 | $15.9M | Buy |
298,605
+24,359
| +9% | +$1.37M | 1.68% | 30 |
|
|
2021
Q2 | $16.7M | Sell |
274,246
-171,780
| -39% | -$9.13M | 2% | 24 |
|
|
2021
Q1 | $21.8M | Sell |
446,026
-11,721
| -3% | -$549K | 2.59% | 13 |
|
|
2020
Q4 | $18.5M | Sell |
457,747
-14,640
| -3% | -$523K | 2.38% | 18 |
|
|
2020
Q3 | $15.4M | Buy |
472,387
+153,788
| +48% | +$4.62M | 2.28% | 19 |
|
|
2020
Q2 | $8.41M | Sell |
318,599
-40
| -0% | -$1.05K | 1.24% | 40 |
|
|
2020
Q1 | $7.94M | Sell |
318,639
-3,520
| -1% | -$109K | 1.59% | 28 |
|
|
2019
Q4 | $11.6M | Buy |
322,159
+16,861
| +6% | +$582K | 1.81% | 24 |
|
|
2019
Q3 | $10.4M | Buy |
305,298
+74,759
| +32% | +$2.39M | 1.75% | 29 |
|
|
2019
Q2 | $6.45M | Buy |
230,539
+630
| +0.3% | +$17.5K | 1.08% | 45 |
|
|
2019
Q1 | $7.13M | Sell |
229,909
-106,500
| -32% | -$2.84M | 1.27% | 40 |
|
|
2018
Q4 | $7.95M | Buy |
336,409
+43,595
| +15% | +$1.19M | 1.61% | 34 |
|
|
2018
Q3 | $11.3M | Buy |
292,814
+79,053
| +37% | +$2.85M | 1.82% | 25 |
|
|
2018
Q2 | $7.16M | Buy |
213,761
+14,860
| +7% | +$529K | 1.29% | 41 |
|
|
2018
Q1 | $7.21M | Buy |
198,901
+10
| +0% | +$346 | 1.31% | 39 |
|
|
2017
Q4 | $6.33M | Sell |
198,891
-1,305
| -0.7% | -$44.7K | 1.19% | 41 |
|
|
2017
Q3 | $7.49M | Sell |
200,196
-960
| -0.5% | -$32.7K | 1.48% | 38 |
|
|
2017
Q2 | $6.28M | Sell |
201,156
-14,460
| -7% | -$418K | 1.29% | 43 |
|
|
2017
Q1 | $5.31M | Buy |
+215,616
| New | +$5.06M | 1.11% | 41 |
|
Other funds holding LMAT
CCA
VCM
CCM
CAM
GCM
VPM
Summit Creek Advisors's LMAT Position: Q1 2026 in Review
Summit Creek Advisors reduced its LeMaitre Vascular (LMAT) stake by 30% in Q1 2026, selling an estimated $4.22M and leaving 105,679 shares worth $11.5M. The position accounts for 2.37% of the portfolio, ranked #13.
Summit Creek Advisors first reported a position in LMAT in Q1 2017 and has held it in 37 quarters since. The position peaked at $21.8M in Q1 2021. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.
- Summit Creek Advisors held 105,679 shares of LeMaitre Vascular worth $11.5M as of Q1 2026.
- Summit Creek Advisors sold 44,317 LeMaitre Vascular shares in Q1 2026, an estimated $4.22M.
- LeMaitre Vascular made up 2.37% of Summit Creek Advisors's portfolio in Q1 2026, its #13 holding.
- Summit Creek Advisors first reported a position in LeMaitre Vascular in Q1 2017 and has held it in 37 quarters since.
- Summit Creek Advisors's LeMaitre Vascular position peaked at $21.8M in Q1 2021.
- 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.
Based on Summit Creek Advisors's 13F filing for Q1 2026, filed 6 May 2026.